News for Synthetic Biologics Inc (SFYC.BE)

Companies Reporting Before The Bell • Toro (NYSE:TTC) is expected to report quarterly earnings at $0.75 per share on revenue of $851.38 ...

Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and fast, with a skew ...

5 Penny Stocks To Buy According To These 4 Analysts I know it’s the weekend of the Big Game, and you may be preparing for the pregame right now. But Monday w...

3 Penny Stocks to Buy With Bullish Analyst Ratings While Covid has helped bring a new focus to biotech penny stocks, there are more reasons why interest in thi...

4 Penny Stocks to Watch on Today Despite the market starting low in the morning, by midday, many penny stocks were up on January 22nd. There are a lot of facto...

Are These Penny Stocks On Your Buy Or Sell List? As we head toward the end of January, many penny stocks are presenting investors with opportunity. With Joe Bi...

Should You Buy Cheap Stocks Under $1 Right Now? When it comes to making money in the stock market, there are plenty of ways to go about it. However, one of the...

This year has gotten off to a strong start already. Many stocks, including penny stocks, are reaching new 52-week and all-time highs. Meanwhile, the broader ...

Are You Following Analysts On These Penny Stocks? This year has gotten off to a strong start already. That goes for penny stocks & blue-chips alike. Many stock...

Penny Stocks Trading Under $2 Right Now To Watch This Week This week is one of the most active weeks for penny stocks. Almost daily, including today, we’re s...

These 5 Biotech Penny Stocks Saw A Surge This Week, Will That Continue? Now that 2020 is behind us, 2021 could be the year for biotech penny stocks to take off...

What's moving these stocks in pre-market hours today?.

What's moving these stocks in pre-market hours today?.

Today's Daily Dose brings you news about the FDA lifting the partial clinical hold on Marker Therapeutics' phase II post-transplant acute myeloid leukemia trial; Rhythm selling its Rare Pediatric Disease Priority Review Voucher for $100 million; Hoth Therapeutics' financing agreement; Millendo discontinuing further development of MLE-301 for the treatment of menopausal vasomotor symptoms.

Are These Penny Stocks on Your Watch List Right Now? With the new year in full swing, investors are recharged and ready to find opportunities. When first searc...